Background: Recurrent urinary tract infections (UTIs) are a common outpatie
nt problem, resulting in frequent office visits and often requiring the use
of prophylactic antimicrobial agents. Patient-initiated treatment of recur
rent UTIs may decrease antimicrobial use and improve patient convenience.
Objective: To determine the safety and feasibility of patient-initiated tre
atment of recurrent UTIs.
Design: Uncontrolled, prospective clinical trial.
Setting: University-based primary health care clinic.
Participants: Women at least 18 years of age with a history of recurrent UT
Is and no recent pregnancy, hypertension, diabetes, or renal disease.
Intervention: After self-diagnosing UTI on the basis of symptoms, participa
ting women initiated therapy with ofloxacin or levofloxacin.
Measurements: Accuracy of self-diagnosis determined by evidence of a defini
te (culture-positive) or probable (sterile pyuria and no alternative diagno
sis) UTI on pretherapy urinalysis and culture. Women with a self-diagnosis
of UTI that was not microbiologically confirmed were evaluated for alternat
ive diagnoses. Post-therapy interviews and urine cultures were used to asse
ss clinical and microbiological cure rates, adverse events, and patient sat
isfaction.
Results: 88 of 172 women self-diagnosed a total of 172 UTIs. Laboratory eva
luation showed a uropathogen in 144 cases (84%), sterile pyuria in 19 cases
(11%), and no pyuria or bacteriuria in 9 cases (5%). Clinical and microbio
logical cures occurred in 92% and 96%, respectively, of culture-confirmed e
pisodes. No serious adverse events occurred.
Conclusion: Adherent women can accurately self-diagnose and self-treat recu
rrent UTIs.